GnRH agonist administration in the luteal phase does not increase clinical pregnancy or implantation rates following ICSI-ET in GnRH agonist or antagonist treated ovarian stimulation cycles

被引:0
|
作者
Ata, B. [1 ]
Yakin, K. [1 ]
Balaban, B. [1 ]
Urman, B. [1 ]
机构
[1] Amer Hosp Istanbul, Assisted Reprod Unit, Istanbul, Turkey
关键词
D O I
10.1016/j.fertnstert.2007.07.566
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:S163 / S163
页数:1
相关论文
共 50 条
  • [1] Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles
    Tesarik, Jan
    Hazout, Andre
    Mendoza-Tesarik, Raquel
    Mendoza, Nicolas
    Mendoza, Carmen
    [J]. HUMAN REPRODUCTION, 2006, 21 (10) : 2572 - 2579
  • [2] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    Filho, J. S. Cunha
    Terres, L. F.
    Holanda, F.
    Freitas, F.
    Glitz, C.
    Genro, V. K.
    Arbo, E.
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2007, 24 (08) : 326 - 330
  • [3] Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol
    J. S. Cunha Filho
    L. F. Terres
    F. Holanda
    F. Freitas
    C. Glitz
    V. K. Genro
    E. Arbo
    [J]. Journal of Assisted Reproduction and Genetics, 2007, 24 : 326 - 330
  • [4] GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonistprotocol: a randomized, controlled double blind study
    Ata, B.
    Yakin, K.
    Balaban, B.
    Urman, B.
    [J]. HUMAN REPRODUCTION, 2008, 23 (03) : 668 - 673
  • [5] A single dose of GnRH agonist as luteal support in ICSI-ET cycles stimulated with a long GnRH agonist protocol. A systematic review and meta-analysis
    Tarlatzi, T. B.
    Kyrou, D.
    Mertzanidou, A.
    Fatemi, H. M.
    Tarlatzis, B. C.
    Devroey, P.
    [J]. HUMAN REPRODUCTION, 2010, 25 : I311 - I311
  • [6] The role of single dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomised study
    Caglar, G. S.
    Isik, A. Z.
    Tuncay, G.
    Akarsu, C.
    Vicdan, K.
    [J]. HUMAN REPRODUCTION, 2007, 22 : I83 - I83
  • [7] Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study
    Isik, A. Z.
    Caglar, G. S.
    Sozen, E.
    Akarsu, C.
    Tuncay, G.
    Ozbicer, T.
    Vicdan, K.
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2009, 19 (04) : 472 - 477
  • [8] Ovarian hyperresponse to luteal phase GnRH-agonist administration
    Depenbusch, Marion
    Diedrich, Klaus
    Griesinger, Georg
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2010, 281 (06) : 1071 - 1072
  • [9] GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol
    Takahashi, K
    Mukaida, T
    Tomiyama, T
    Goto, T
    Oka, C
    [J]. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2004, 21 (09) : 317 - 322
  • [10] Ovarian hyperresponse to luteal phase GnRH-agonist administration
    Marion Depenbusch
    Klaus Diedrich
    Georg Griesinger
    [J]. Archives of Gynecology and Obstetrics, 2010, 281 : 1071 - 1072